Biopharmaceutical industry and healthcare are being transformed by a variety of novel technolgies coming into research and business practises. From artificial intelligence and big data tools, to quantum computing, next generation proteomics, and virtual reality -- novel technologies are disrupting the traditional research and business models, and helping innovate at a greater scale, faster, and cheaper.
Aug. 11, 2022
by Natalia Honchar
Biopharma insight
Nanomedicines, as it goes from the name, are nanotechnology-based drugs, used for the treatment, diagnosis or prevention of various diseases. …
March 15, 2021
by Satnam Surae
Biopharma insight
Covid-19 is still having a devastating effect on many countries and economies worldwide and has brought to light the impact …
June 6, 2022
by Andrii Buvailo
News
Hong Kong-based pioneer of the artificial intelligence (AI)-driven drug discovery, a clinical stage biotech Insilico Medicine, has completed a $60 …
Dec. 28, 2022
by Andrii Buvailo
Interview
The aging research industry has exploded in recent years. Once a fringe area of science, aging research has now gained …
Jan. 26, 2022
by Andrii Buvailo
Biopharma insight
Artificial Intelligence (AI) in drug discovery is now on a steep rise. A growing number of companies compete to develop …
Sept. 7, 2022
by Andrii Buvailo
Biopharma insight
The concept of deoxyribonucleic acid (DNA)-encoded chemical libraries was invented three decades ago, but only recently it has become a …
Aug. 24, 2022
by Joseph Pareti
Biopharma insight
AstraZeneca has achieved outstanding results in drug design using large language models applied to SMILES representation of molecules; but what are …
July 15, 2021
by David Levy
Biopharma insight
The future of the connected world is not just about the newest frontier technologies, such as high-band 5G. It will …
Feb. 4, 2020
by Peter Jarowski
Biopharma insight
Chemical Data Has Problems The state of data access, quality and dissemination in Chemistry is extremely poor - so poor …
April 27, 2023
by Sabina Lee
Biopharma insight
Sponsored by Syntekabio
STB CLOUD is Syntekabio’s latest cloud-based, fully automated AI platform. It’s designed for developers to engage in their drug discovery …
July 11, 2020
by Andrii Buvailo
Biopharma insight
What do antibiotic-resistant bacteria (“superbugs”) and coronaviruses have in common? They both can kill lots of people globally, and they …
June 8, 2022
by Andrii Buvailo
Interview
Acesis Biomed, a biotechnology company based in the US and the UK, is developing an innovative solution for the treatment …